Michael Kinnaman, MD

Regeneron Pharmaceuticals – Medical Director, Clinical Sciences/Oncology

In 2023, Dr. Kinnaman assumed the role of Medical Director in the Clinical Sciences/Oncology group on Regeneron Pharmaceuticals where he spearheads the development and oversight of clinical studies focused on novel therapeutic agents. Previously, he was an integral part of the Pediatric Sarcoma Service at Memorial Sloan Kettering Cancer Center, dedicating his efforts to treating children, adolescents, and young adults with pediatric sarcomas. His research, particularly with the Iacobuzio-Donahue Lab Group, aimed at unraveling the clonal evolution of cancer cells in pediatric sarcomas, marking significant contributions to the field.

Dr. Kinnaman obtained his MD from Stony Brook University School of Medicine, followed by a pediatric residency at Children’s Hospital at Montefiore.